| mRNA |
paclitaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.0054 |
0.9 |